Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Discovery of unusual biosynthetic pathways could aid in the search for new natural products

Discovery of unusual biosynthetic pathways could aid in the search for new natural products

Bacteria are master engineers of small, biologically useful molecules. A new study in Nature Communications has revealed one of the tricks of this microbial trade: synthesizing and then later inserting a nitrogen-nitrogen bond, like a prefabricated part, into a larger molecule.

The discovery was made by a collaborative group of chemists at the University of Illinois and Harvard University. Together, they confirmed that two otherwise unrelated, bacterially-produced compounds shared an unusual set of steps in their biosynthetic pathways. Deciphering this type of biochemical process will aid in the search for other useful biological compounds.

“It’s a molecular handle or genetic handle if you wish to now go after other new molecules that people haven’t found before,” said Wilfred van der Donk, Richard E. Heckert Endowed Chair in Chemistry and Investigator of the Howard Hughes Medical Institute. “So we’re pretty excited both about what’s in the paper and also what it allows us to do going forward.”

Natural products, substances produced by living things, have provided us with antibiotics, antifungals, cancer therapies, and other important pharmaceutical and industrial compounds; continued exploration of the diverse chemical world of microbes is one of our best hopes for future drug discovery. A major focus of van der Donk’s research is the quest to identify new natural products.

Van der Donk shares that goal with a collaborative research team within the Carl R. Woese Institute for Genomic Biology (IGB), of which he is a member. The Mining Microbial Genomes research team aims to accelerate the natural product hunt using the power of next-generation genomic technologies. The tools that bacteria and other microbes use to make natural products are enzymes, specialized proteins encoded by genes. The team’s long-term research goal is to learn to read through bacterial genomes and, based on the genes each species possesses, predict what compounds they are able to make.

The team is especially interested in a class of molecules called phosphonates that has already yielded multiple useful compounds. At the outset of the present study, they wanted to understand what gene products enable a cell to form a key feature of a particular phosphonate called fosfazinomycin, a compound with antifungal properties: a chemical bond between two nitrogen atoms. Compounds with reactive nitrogen-nitrogen bonds readily react with other molecules such as DNA and proteins and as such may contribute to antimicrobial or anti-cancer activity.

“We were looking for fosfazinomycin as a group for probably a decade, because of the very unusual structure, but we didn’t know which genes” provided the enzymes to synthesize it, van der Donk explained. “We decided okay, let’s figure out how nature makes this nitrogen-nitrogen bond.”

After the group began work on the project, two publications by researchers focused on other natural products described a process of nitrogen-nitrogen bond formation in which one nitrogen atom is built into the molecule, and another is later attached–the organism is building the molecule piece by piece, like a child with a basic pack of Lego bricks.

Van der Donk’s group discovered with surprise that their molecule’s nitrogen-nitrogen bond was not being formed this way. Instead, the bacteria they studied were creating nitrogen-nitrogen bonds as part of a much smaller molecule, like a specialty Lego part, and later installing that part into the larger molecule that would become fosfazinomycin.

“We realized as we continued working that in our system, it’s done very differently,” van der Donk said. “It looked like in our case as if nature was making this nitrogen-nitrogen bond containing molecule as a prepackaged molecular entity that then later on was dumped into an existing biosynthetic pathway.”

The research project took another serendipitous turn when graduate student and co-first author Kwo-Kwang (Abraham) Wang presented the preliminary results at a conference. He was approached by Harvard chemistry graduate student Tai Ng, who along with his laboratory group led by Professor Emily Balskus was studying a natural product and promising anti-cancer agent called kinamycin. Kinamycin contains a nitrogen-nitrogen bond, and Ng’s research suggested that it also shares the prefabrication step suspected for fosfazinomycin.

“We had noticed that their molecule [is synthesized using] the same genes, but we didn’t really know how that fit in either, because they are making a completely different nitrogen-nitrogen bond containing structure that doesn’t look anything like our molecule,” van der Donk said. The two groups began to work together, coordinating experiments in which labeled molecules were fed to bacteria able to synthesize each of the two natural products, to see what intermediate molecular structures could be seamlessly introduced into the natural biosynthesis pathway within the cell.

“We would make these labeled compounds, give them to the producing organism, isolate the final product, for the Harvard group kinamycin and for us fosfazinomycin, and see whether the nitrogen-nitrogen moiety of the molecules that we were feeding to these organisms was installed into the final product,” van der Donk said. “We did that for four different compounds and every time the answer was yes, yes, yes, yes.”

Finding this improbable commonality in the way two dissimilar molecules are produced increased the researchers’ confidence in the functional roles of the genes involved. They now have a new genomic signature to add to their lexicon, something they can scan for in other bacterial genomes as they continue the search for useful natural products.

“We need to learn more about how known natural products are made. This is a great example; now that we know, we can use that knowledge. Before that, it was just a whole bunch of genes and we didn’t really know what to do with them,” van der Donk said. “By going after unknown gene clusters [we hope to be able to] see immediately from the gene cluster, this has to be a new molecule . . . could that molecule be the next antibiotic or the next anti-tumor drug?”

Source:

https://www.igb.illinois.edu/article/unusual-biosynthetic-pathway-offers-key-future-natural-product-discovery

Tagged with:

About author

Related Articles